Scott D Ramsey (Scott Ramsey)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 30

Top Topics

Sickle Cell Disease

Palliative Care

Hematopoietic Stem Cell

Top Venues

JCO oncology practice

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Annals of internal medicine

PharmacoEconomics - open

This page only lists publications with an associated author ORCID identifier.

Publications

Wael Saber, Aasthaa Bansal, Lily Li, Bart L Scott, Lindsey R Sangaralingham, Viengneesee Thao, Joshua A Roth, Winona Wright, Lotte M G Steuten, Joseph A Pidala, Asmita Mishra, Richard T Maziarz, Peter Westervelt, Joseph P McGuirk, Corey S Cutler, Ryotaro Nakamura, Scott D Ramsey
Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102. JCO oncology practice 20 (4) (2024)
Wael Saber, Aasthaa Bansal, Lily Li, Bart L Scott, Lindsey R Sangaralingham, Viengneesee Thao, Joshua A Roth, Winona Wright, Lotte M G Steuten, Joseph A Pidala, Asmita Mishra, Richard T Maziarz, Peter Westervelt, Joseph P McGuirk, Corey S Cutler, Ryotaro Nakamura, Scott D Ramsey
Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102. JCO oncology practice (2024)
Wael Saber, Aasthaa Bansal, Lily Li, Bart L Scott, Lindsey R Sangaralingham, Viengneesee Thao, Joshua A Roth, Winona Wright, Lotte M G Steuten, Joseph A Pidala, Asmita Mishra, Richard T Maziarz, Peter Westervelt, Joseph P McGuirk, Corey S Cutler, Ryotaro Nakamura, Scott D Ramsey
Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102. JCO oncology practice 20 (4) (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine 177 (2) (2024)
Scott D Ramsey, Arzu Onar-Thomas, Stephanie B Wheeler
Real-World Database Studies in Oncology: A Call for Standards. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine 177 (2) (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine 177 (2) (2024)
Anirban Basu, Aaron N Winn, Kate M Johnson, Boshen Jiao, Emily Beth Devine, Jane Silva Hankins, Staci D Arnold, M A Bender, Scott D Ramsey
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis. Annals of internal medicine 177 (2) (2024)
Scott D Ramsey, Arzu Onar-Thomas, Stephanie B Wheeler
Real-World Database Studies in Oncology: A Call for Standards. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Scott D Ramsey, Arzu Onar-Thomas, Stephanie B Wheeler
Real-World Database Studies in Oncology: A Call for Standards. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Aaron Winn, Anirban Basu, Scott D Ramsey
A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of America. PharmacoEconomics - open (2023)
Gary H Lyman, Aasthaa Bansal, Sean D Sullivan, Kathryn B Arnold, William E Barlow, Dawn L Hershman, Thomas E Lad, Scott D Ramsey
Impact of treatment experience on patient knowledge of colony-stimulating factors among patients receiving cancer chemotherapy: evidence from S1415CD-a large pragmatic trial. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 31 (10) (2023)
Riha Vaidya, Joseph M Unger, Stephen Caldwell, Jessica P Hwang, Rashmi Chugh, Monica A Tincopa, Kathryn B Arnold, Dawn L Hershman, Scott D Ramsey
Universal Viral Screening of Newly Diagnosed Cancer Patients in the United States: A Cost Efficiency Evaluation. Cancer research communications (2023)
Hiba M Khan, Scott D Ramsey, Veena Shankaran
Financial Toxicity in Cancer Care: Implications for Clinical Care and Potential Practice Solutions. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Joanne M Jeter, Lisa A Kottschade, Robert R McWilliams, Nikhil I Khushalani, Sekwon Jang, Sigrun Hallmeyer, David H McDermott, Hussein A Tawbi, Min Che, Cho-Han Lee, Corey Ritchings, Trong Kim Le, Boas Park, Scott D Ramsey
Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study. Immunotherapy (2023)
Dawn L Hershman, Aasthaa Bansal, William E Barlow, Kathryn B Arnold, Kate Watabayashi, Ari Bell-Brown, Sean D Sullivan, Gary H Lyman, Scott D Ramsey
Intervention Nonadherence in the TrACER (S1415CD) Study: A Pragmatic Randomized Trial of a Standardized Order Entry for CSF Prescribing. JCO oncology practice (2023)
Dawn L Hershman, Aasthaa Bansal, Sean D Sullivan, William E Barlow, Kathryn B Arnold, Kate Watabayashi, Ari Bell-Brown, Nguyet A Le-Lindqwister, Carrie L Dul, Ursa A Brown-Glaberman, Robert J Behrens, Victor Vogel, Nitya Alluri, Scott D Ramsey
A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Veena Shankaran, Lily Li, Catherine R Fedorenko, Hayley A Sanchez, Yuxian Du, Sara Khor, Karma Kreizenbeck, Scott D Ramsey
Risk of Adverse Financial Events in Patients With Cancer: Evidence From a Novel Linkage Between Cancer Registry and Credit Records. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (8) (2022)
Scott D Ramsey, Jonathan W Friedberg, John V Cox, Jeffrey M Peppercorn
Economic Analysis of Screening, Diagnostic, and Treatment Technologies for Cancer: Reflections and a Roadmap for Prospective Authors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jessica P Hwang, Andrew S Artz, Parth D Shah, Banu E Symington, Jordan J Feld, Sarah P Hammond, Emmy Ludwig, Amy Pai, Scott D Ramsey, Ilana Schlam, Jennifer M Suga, Su H Wang, Mark R Somerfield
Practical Implementation of Universal Hepatitis B Virus Screening for Patients With Cancer. JCO oncology practice 18 (9) (2022)
Scott D Ramsey, M A Bender, Li Li, Kate M Johnson, Boshen Jiao, Beth Devine, Anirban Basu
Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance-A retrospective cohort study. PloS one 17 (11) (2022)
Laura E Panattoni, Cara L McDermott, Lily Li, Qin Sun, Catherine R Fedorenko, Hayley A Sanchez, Karma L Kreizenbeck, Veena Shankaran, Scott D Ramsey
Effect of the COVID-19 Pandemic on Place of Death Among Medicaid and Commercially Insured Patients With Cancer in Washington State. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Scott D Ramsey, Jonanthan W Friedberg, John V Cox, Jeffrey M Peppercorn
Economic Analysis of Screening, Diagnostic, and Treatment Technologies for Cancer: Reflections and a Roadmap for Prospective Authors. JCO oncology practice 18 (11) (2022)
Ali Tafazzoli, Scott D Ramsey, Alissa Shaul, Ameya Chavan, Weicheng Ye, Anuraag R Kansal, Josh Ofman, A Mark Fendrick
The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA. PharmacoEconomics 40 (11) (2022)
Joshua A Roth, Meghna S Trivedi, Stacy W Gray, Donald L Patrick, Debbie M Delaney, Kate Watabayashi, Paul Litwin, Parth Shah, Katherine D Crew, Monica Yee, Mary W Redman, Joseph M Unger, Vassiliki Papadimitrakopoulou, Judy Johnson, Karen Kelly, David R Gandara, Roy S Herbst, Dawn L Hershman, Scott D Ramsey
Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN). JCO oncology practice 17 (11) (2021)
Joseph M Unger, Anna B Moseley, Christabel K Cheung, Raymond U Osarogiagbon, Banu Symington, Scott D Ramsey, Dawn L Hershman
Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Josh J Carlson, Gregory F Guzauskas, Robert A Dann, Scott D Ramsey
Budget impact analysis of the DiviTum TKa assay in postmenopausal women with hormone receptor positive metastatic breast cancer. Journal of medical economics 24 (1) (2021)
Ali Raza Khaki, Shasank Chennupati, Catherine R Fedorenko, Lily Li, Qin Sun, Petros D Grivas, Scott D Ramsey, Stephen M Schwartz, Veena Shankaran
Utilization of Systemic Therapy in Patients With Cancer Near the End of Life in the Pre- Versus Postimmune Checkpoint Inhibitor Eras. JCO oncology practice 17 (11) (2021)
Cristina Merkhofer, Shasank Chennupati, Qin Sun, Keith D Eaton, Renato G Martins, Scott D Ramsey, Bernardo H L Goulart
Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non-Small-Cell Lung Cancer. JCO oncology practice 17 (8) (2021)